SCHEMBL7799064

SCHEMBL7799064

O=C(O)c1ccccc1C1=NN1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
ALOX15 P16050 1/20 0.52
KDM4E B2RXH2 4/20 0.49
RAB9A P51151 3/20 0.49
MYC P01106 1/20 0.48
FOLH1 Q04609 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX12 P18054 1/20 0.47
POLB P06746 1/20 0.46
HNF4A P41235 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
HMGB1 P09429 1/20 0.45
HPGD P15428 1/20 0.45
CA4 P22748 1/20 0.45
CA6 P23280 1/20 0.45
CA7 P43166 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29726703 1.00 ALDH1A1 (0.52) ALDH1A1ALOX15KDM4ERAB9AMYC
SCHEMBL36145 0.79 ALDH1A1 (0.72) ALDH1A1ALOX15KDM4EMYCFOLH1
SCHEMBL30028907 0.79 ALDH1A1 (0.72) ALDH1A1ALOX15KDM4EMYCFOLH1
Hydrochloric Acid SCHEMBL7579852 0.77 ALDH1A1 (0.68) ALDH1A1ALOX15KDM4EMYCFOLH1
Hydrochloric Acid SCHEMBL1681943 0.77 ALDH1A1 (0.68) ALDH1A1ALOX15KDM4EMYCFOLH1
SCHEMBL28408894 0.77 ALDH1A1 (0.68) ALDH1A1ALOX15KDM4EMYCFOLH1
SCHEMBL2830888 0.77 ALDH1A1 (0.68) ALDH1A1ALOX15KDM4EMYCFOLH1
Hydrochloric Acid SCHEMBL10888462 0.77 ALDH1A1 (0.68) ALDH1A1ALOX15KDM4EMYCFOLH1
SCHEMBL30620175 0.77 ALDH1A1 (0.68) ALDH1A1ALOX15KDM4EMYCFOLH1
SCHEMBL9636797 0.77 ALDH1A1 (0.68) ALDH1A1ALOX15KDM4EMYCFOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010027248-A1 Novel receptor SMITHKLINE BEECHAM P.L.C. 2001-10-04 US disclosed
US-6245893-B1 ANTICONVULSANTS, USE IN TREATMENT OR PREVENTION OF NERVOUS SYSTEM DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2001-06-12 US disclosed
US-5985334-A Screening methods to identify anti-convulsant compounds SMITHKLINE BEECHAM P.L.C. (GB) 1999-11-16 US disclosed
EP-0807122-A1 NOVEL RECEPTOR SMITHKLINE BEECHAM PLC (GB) 1997-11-19 EP disclosed
WO-1996018650-A1 NOVEL RECEPTOR SMITHKLINE BEECHAM P.L.C. (GB) 1996-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010027248-A1 Novel receptor ADGRF1, TACR2, GPR4 ALDH1A1 4099/4885ALOX15 3988/4885KDM4E 4395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.